Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
10.52
+0.08 (0.77%)
Feb 3, 2026, 3:00 PM CST
SHA:600420 Market Cap
SHA:600420 has a market cap or net worth of 14 billion as of February 3, 2026. Its market cap has decreased by -11.75% in one year.
Market Cap
14.00B
Enterprise Value
11.97B
Revenue
9.36B
Ranking
n/a
PE Ratio
14.83
Stock Price
10.52
Market Cap Chart
Since August 23, 2004, SHA:600420's market cap has increased from 833.55M to 14.00B, an increase of 1,579.78%. That is a compound annual growth rate of 14.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 14.00B | 3.37% |
| Dec 31, 2025 | 13.55B | -15.41% |
| Dec 31, 2024 | 16.01B | 21.96% |
| Dec 29, 2023 | 13.13B | 40.50% |
| Dec 30, 2022 | 9.35B | -12.25% |
| Dec 31, 2021 | 10.65B | 9.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Aosaikang Pharmaceutical | 15.41B |
| Nanjing King-Friend Biochemical Pharmaceutical | 14.99B |
| ApicHope Pharmaceutical Group | 14.80B |
| Shanghai Haoyuan Chemexpress | 14.70B |
| Guobang Pharma | 14.35B |
| Zhejiang Medicine | 13.60B |
| Zhejiang Jingxin Pharmaceutical | 13.53B |
| Wedge Industrial | 13.44B |